Dr. Dominique Darvas is co-founder and CEO of HALOS Biosciences, developing the world's first lab-cultured human fetal plasma. This platform technology replaces fetal bovine serum and human blood-derived cell culture supplements, enables immune therapies, and serves as a substrate for regenerative medicine and human rejuvenation. She trained as a physician (MD) and earned a PhD in emergency blood transfusion protocols at Aix-Marseille, followed by a second thesis on mitohormesis during her longevity medicine specialization at Université Paris Descartes. She also co-founded Clinique Cleage Genève, an anti-aging clinic still thriving today, and serves as a fellow and counsellor at the Longevity Biotech Fellowship.